Status:
UNKNOWN
Similarities and Differences of Biological Therapies for Severe Asthma.
Lead Sponsor:
Clinica Universidad de Navarra, Universidad de Navarra
Collaborating Sponsors:
Hospital Clinic of Barcelona
Hospital Regional de Malaga
Conditions:
Asthma
Eligibility:
All Genders
Brief Summary
This is an ambispective multicenter longitudinal observational study to evaluate the efficacy and safety profile of biological therapies in patients diagnosed with severe asthma in real life condition...
Detailed Description
The use of biologicals to treat severe asthma has been implemented in a regular basis while information on long term effectiveness and safety is lacking. It is necessary to establish strategies to clo...
Eligibility Criteria
Inclusion
- Individuals of any age: adults and children.
- Diagnosis of severe asthma as given by the treating physician, and defined as an asthma that remains uncontrolled in despite adherence with maximal optimized therapy and treatment of contributed factors, or asthma that worsens when high dose treatment is decreased.
- Being treated or not (control group) with biological drugs.
- Signed Informed Consent.
Exclusion
- None.
Key Trial Info
Start Date :
April 7 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
November 1 2022
Estimated Enrollment :
600 Patients enrolled
Trial Details
Trial ID
NCT04665141
Start Date
April 7 2021
End Date
November 1 2022
Last Update
April 27 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Civil-Hospital Regional Universitario de Málaga
Málaga, Spain, 29009